Diagnoses Associated With Persistent Elevation of Creatine Kinase

Status Completed

Clinical Trial Summary

Serum creatinine kinase (CK) level varies with age, gender, race and physical activity. For these reasons there is no normal serum CK level. Many pathological situations cause hyperCKemia, such as neuromuscular disorders (muscular dystrophy, inflammatory myositis, mitochondrial myopathy) and multiple systemic causes. The diagnostic approach to pauci or asymtomatic hyperCKemia can therefore be difficult and lead to multiple, and sometimes invasive tests, such as muscle biopsy. This study aims to describe the diagnoses associated with persistent elevation of serum creatine kinase and to precise the role of the muscule biopsy.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04838509
Study type	Observational
Source	Central Hospital, Nancy, France
Contact
Status	Completed
Phase
Start date	May 1, 2021
Completion date	June 24, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00199745` - Differences in Atorvastatin Metabolite Ratios as a Diagnostic Tool in Detecting Atorvastatin Induced Myotoxicity	Phase 4
Completed	`NCT03979157` - Non-invasive Molecular Imaging of Muscle Structure (MSOT_muscles)	N/A
Completed	`NCT04115475` - New Imaging Biomarkers for Muscular Diseases - Multispectral Optoacoustic Imaging in Spinal Muscular Atrophy	N/A
Completed	`NCT03354767` - The Role of Ischaemia-reperfusion Injury in the Pathogenesis of Muscle Wasting After Thoracic Aortic Surgery	N/A
Completed	`NCT03440034` - Study of Pioglitazone in Sporadic Inclusion Body Myositis	Phase 1
Completed	`NCT03406780` - A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy	Phase 2
Completed	`NCT01826487` - Phase 3 Study of Ataluren in Participants With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD)	Phase 3
Terminated	`NCT02090959` - An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy	Phase 3
Recruiting	`NCT05126758` - A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy	Phase 3
Recruiting	`NCT05183152` - Non-invasive BCI-controlled Assistive Devices	N/A
Completed	`NCT03179631` - Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy	Phase 3
Terminated	`NCT02829814` - Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With Fibromyalgia	Phase 3
Recruiting	`NCT06226376` - Mollii Suit and Fibromyalgia (EXOFIB 2)	N/A
Completed	`NCT03211390` - Using Telemedicine to Improve Spasticity Diagnosis Rates
Completed	`NCT03250988` - Prevalence of Comorbid Spasticity and Urinary Incontinence in Residents of a Long-Term Care Facility
Completed	`NCT03209960` - Validity and Inter-Rater Reliability of a Novel Bedside Referral Tool for Spasticity
Completed	`NCT00609063` - The Effect of Statin Medications on Muscle Performance (The STOMP Study)	N/A
Terminated	`NCT00240981` - TOM: Testosterone in Older Men With Sarcopenia	Phase 4
Completed	`NCT03268421` - Fibromyalgia Integrative Training for Adolescents With Juvenile Fibromyalgia	N/A
Completed	`NCT05730842` - Absorption, Metabolism, Excretion and Absolute Bioavailability of EDG-5506 in Healthy Volunteers	Phase 1